We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA has asked for more information on the pen injector device used in Sanofi and Zealand Pharma's IGlarLixi combination product for diabetes, and extended its review by three months, hurting its chances to be the first product of its kind on the U.S. market. Read More
The FDA has approved Pfizer’s Troxyca extended-release capsules for oral use in patients who require long-term opioid treatment to manage severe pain. Read More
The U.S. Judicial Panel on Multidistrict Litigation is consolidating price-fixing suits against generics makers Covis Pharmaceuticals’ heart drug Lanoxin in Pennsylvania federal court. Read More
Healthcare providers spent $121 billion on prescription drugs covered under the Medicare Part D program in 2014, representing a 12.6 rise in spending from 2013. Read More